Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Clinical trial NCT00578097 · TERMINATED

Trial details

NCT number: NCT00578097
Sponsor: Ipsen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2008-02-01
Primary completion: 2009-06-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.